EV Therapeutics
PrivateLast Round
Accelerator
Sep 20, 2023
Company Overview
EV Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in September 2023.
EV Therapeutics is a biotechnology company developing off-the-shelf neoantigen-based immunotherapies from tumor-derived extracellular vesicles to treat advanced-stage cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EV Therapeutics Comparables
Compare EV Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diadem Biotherapeutics | 84% | |
| Vanquish Bio | 80% | |
| UbiVac, Inc. | 79% |
For institutional investors. Book with your work email.
EV Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 20, 2023 | ||||
| Angel | Jul 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EV Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Minnesota | Angel |
| California Life Sciences | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 278% MoM.
- Jan 8, 2026
Monthly visitors grew 96% MoM.
For institutional investors. Book with your work email.
EV Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EV Therapeutics's valuation, stock price, and market status.
Is EV Therapeutics a public or private company?
EV Therapeutics is a private company.
What is the current stock price of EV Therapeutics?
EV Therapeutics is a private company, so its shares have no public market price. Caplight tracks EV Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EV Therapeutics worth (valuation)?
Valuation information for EV Therapeutics is not publicly available.
Can I buy EV Therapeutics stock?
EV Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EV Therapeutics's last funding round?
EV Therapeutics's most recent funding round was Accelerator on September 20, 2023.
Who are the main investors in EV Therapeutics?
Key investors in EV Therapeutics include University of Minnesota, California Life Sciences.
Will EV Therapeutics IPO soon?
No public IPO plans have been announced for EV Therapeutics.
How can I track EV Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in EV Therapeutics's shares on secondary markets.